Carregant...

HBV genotypes and drug resistance mutations in antiretroviral treatment-naïve and treatment-experienced HBV-HIV co-infected patients

BACKGROUND: The presence of hepatitis B virus (HBV) resistance mutations upon initiation or during antiretroviral therapy (ART) in HIV co-infected patients is an important determinant of treatment response. The main objective of the study was to determine the prevalence of HBV resistance mutations i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antivir Ther
Autors principals: Archampong, Timothy N. A., Boyce, Ceejay L., Lartey, Margaret, Sagoe, Kwamena W., Obo-Akwa, Adjoa, Kenu, Ernest, Blackard, Jason T., Kwara, Awewura
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5106338/
https://ncbi.nlm.nih.gov/pubmed/27167598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP3055
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!